GlassScriptPhysician profile
Moumita Biswas
NPI 1205385812
$4,894.62
in general payments reported to CMS, 2019-2025
38 companies · $928 in 2025
The $928 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7.33 · 2020: $703 · 2021: $320 · 2022: $481 · 2023: $1,416 · 2024: $1,039 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,054 · Education: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,053.57 |
| Education | $329.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $666.56 | 2020-2025 | Airsupra, Breztri |
| Abbvie INC. | $572.16 | 2023-2025 | Vraylar, Ubrelvy, Qulipta |
| Astellas Pharma US INC | $432.58 | 2023-2025 | Veozah |
| Pfizer INC. | $418.05 | 2022-2025 | |
| Lilly USA, LLC | $357.24 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $189.89 | 2022-2025 | Evenity, Repatha, Prolia |
| Novo Nordisk INC | $144.78 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $134.66 | 2022-2024 | Hawkone |
| Teva Pharmaceuticals USA, INC. | $125.34 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $124.93 | 2023 | Rexulti |
| Allergan, INC. | $124.84 | 2020 | |
| Phathom Pharmaceuticals, INC. | $119.25 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $112.51 | 2023-2025 | Auvelity, Sunosi |
| Blue Earth Diagnostics | $110.02 | 2023 | |
| Incyte Corporation | $108.80 | 2025 | Monjuvi |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moumita Biswas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.